Twist Bioscience Corporation (TWST) Operating income 2017–2025
Twist Bioscience Corporation (TWST) annual operating income history from SEC filings — each fiscal year as reported.
-$136.3MFY2025 · since FY2017: -$58.5M → -$136.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$136.3M | +38.3% |
| FY2024 | -$220.8M | -1.7% |
| FY2023 | -$217.2M | +7.5% |
| FY2022 | -$234.8M | -53.7% |
| FY2021 | -$152.7M | -9.0% |
| FY2020 | -$140.1M | -28.7% |
| FY2019 | -$108.8M | -54.3% |
| FY2018 | -$70.6M | -20.7% |
| FY2017 | -$58.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating marginTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →